Is Abbott's Exact Sciences Deal And Nutrition Pivot Altering The Investment Case For Abbott (ABT)? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
diagnostics, and outlined a new volume-led Nutrition strategy after a 6% sales decline, while continuing to face significant infant formula litigation and regulatory scrutiny. These developments have prompted analysts and commentators to reassess Abbott's execution risks and diversification benefits, balancing dilution from the Exact Sciences deal against long-term growth ambitions and its long-running dividend track record. We'll now examine how Abbott's Exact Sciences acquisition and Nutrition pivot reshape the existing investment narrative and the risks investors are weighing. AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery . The best part - they are all under $10b in market cap - there's still time to get in early. Abbott Laboratories Investment Narrative Recap To own Abbott today, you need to believe its diversified devices, diagnostics, and nutrition portfolio can offset near term earnings pressure fr
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- HIV Diagnostics Market Size to Value USD 2.10 Billion by 2035, Growing at a 5.10% CAGR – SNS Insider [Yahoo! Finance]Yahoo! Finance
- Abbott Diabetes And Cancer Milestones Contrast With Prolonged Share Price Weakness [Yahoo! Finance]Yahoo! Finance
- Blood Glucose Monitor Market Expected to Reach USD 25.4 Billion by 2030 | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Lab-on-a-Chip Market Size to Hit USD 20.62 Billion by 2035 | SNS Insider [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories: A Better Than 5 Years Ago - But Still Not A Buy [Seeking Alpha]Seeking Alpha
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 5/27/26 - Form SD
- 5/15/26 - Form 144
- 4/29/26 - Form 4
- ABT's page on the SEC website